MedPath

A study to compare between two anti hypertensive drugs in pregnancy induced hypertensio

Phase 4
Conditions
Health Condition 1: null- Severe pregnancy induced hypertension
Registration Number
CTRI/2017/06/008943
Lead Sponsor
College of Medicine and JNM Hospital West Bengal University of Health Sciences Kalyani
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
113
Inclusion Criteria

Pregnancy more than 20weeks and

Severe Pregnancy Induced Hypertension (systolic blood pressure of 160mmHg or more and /or diastolic blood pressure of 110mmHg or more)

Exclusion Criteria

Pregnancy beyond less than 20 weeks gestational age

Who do not agree for consent.

Contraindication or known allergy to hydralazine or labetalol

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath